eXoZymes, Inc. (EXOZ)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $37.13M
Last updated: Nov 17, 2026 at 4:10 PM ET
eXoZymes, Inc. (EXOZ) Statistics
eXoZymes (EXOZ) has a market cap of $37.13M and an enterprise value of $33.90M. Revenue fell 100.00% over the last 12 months from the 12 months before. Its share count is up 10.80% from a year earlier.
Total Valuation
Enterprise value is 8.70% below the market cap, as cash exceeds debt.
| Market Cap | $37.13M |
|---|---|
| Enterprise Value | $33.90M |
| Latest price (Nov 17, 2026) | $3.50 |
Key Dates
The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 29, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 13, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 77.06% over 52 weeks and trades 30.00% below its 50-day average.
| Beta (1Y) | 0.77 |
|---|---|
| 52-Week Change | -77.06% |
| 1-Month Change | -12.50% |
| 3-Month Change | -45.31% |
| 6-Month Change | -63.16% |
| Total Return (1Y) | -77.06% |
| Return vs SPY (1Y) | -87.45% |
| Max Drawdown (1Y) | -78.36% |
| Max Drawdown (3Y) | -82.94% |
| Sharpe Ratio (1Y) | -1.84 |
| Correlation with SPY (1Y) | 0.14 |
| 50-Day Average | $5.00 |
| 200-Day Average | $7.36 |
| 52-Week Range | $3.24 to $16.90 |
| RSI (14 Days) | 33.9 |
| Average Volume (20 Days) | 13.68K |
Financial Position
Current assets cover 2.30x current liabilities, and total debt is 0.01x shareholder equity.
| Current Ratio | 2.30x |
|---|---|
| Quick Ratio | 2.30x |
| Debt / Equity | 0.01x |
Returns and Efficiency
Return on invested capital is -455.55% and return on equity is -462.82% over the last 12 months.
| Return on Equity (ROE) | -462.82% |
|---|---|
| Return on Assets (ROA) | -173.00% |
| Return on Invested Capital (ROIC) | -455.55% |
| Return on Capital Employed (ROCE) | -245.31% |
| ROA (5Y Average) | -71.83% |
Scores
EXOZ has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$3.99M |
| Operating Income | -$11.08M |
| Pretax Income | -$10.25M |
| Net Income | -$10.14M |
| EBITDA | -$9.96M |
| EBIT | -$10.22M |
| Reported EPS (TTM) | -$1.17 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 37.37% of the $5.86M in total assets.
| Cash and Equivalents | $3.26M |
|---|---|
| Total Debt | $28.98K |
| Net Cash | $3.23M |
| Net Cash Per Share | $0.35 |
| Working Capital | $2.21M |
| Shareholder Equity | $2.19M |
| Book Value Per Share | $0.24 |
| Total Assets | $5.86M |
| Total Liabilities | $3.67M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $442.57K of capital spending, operating cash flow left -$7.80M of free cash flow.
| Operating Cash Flow | -$7.36M |
|---|---|
| Capital Expenditures | $442.57K |
| Free Cash Flow | -$7.80M |
| FCF Per Share | -$0.84 |
| Depreciation and Amortization | $361.80K |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
EXOZ does not pay a dividend. Its free cash flow yield is -23.99%.
| FCF Yield | -23.99% |
|---|---|
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.00% |
Peer Position
Against 3 similar companies, EXOZ has the lowest ROIC.
ROICPeer median 22.19%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -93.91%
| ROIC | -455.55% vs 22.19% median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -100.00% vs -93.91% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About EXOZ
What is EXOZ's market cap?
eXoZymes has a market cap of $37.13M. Its enterprise value, which adds debt and subtracts cash, is $33.90M.
How many shares of EXOZ are outstanding?
eXoZymes has 9.29M shares outstanding. The count is up 10.80% from a year earlier.
Does EXOZ pay a dividend?
No. eXoZymes does not pay a dividend.
How much debt does EXOZ have?
eXoZymes has $28.98K of total debt and $3.26M of cash and equivalents, a net cash position of $3.23M.
EXOZ pages: Overview, Charting, Forecast, Financials, Statistics, Competitors